Redwood Bioscience owns the SMARTag Antibody-Drug Conjugate (ADC) technology platform.

Create assistive equipment that makes a difference in the lives of disabled people, fulfill ergonomic needs, and help others.

Ology is an integrated biopharmaceutical company with a focus on development and manufacturing as well as having expertise in preclinical and clinical development, formulation optimization, and cGMP manufacturing of biopharmaceutical products and medical devices.

O.N. Diagnostics’ mission is to improve patient outcomes by developing non-invasive and clinically effective diagnostic applications that quantitatively exploit the richness of information in CT scans.

the Emeryville campus focuses on early discovery and research activities as a hub for infectious disease research, with additional expertise in structural and biophysical chemistry, computer-aided drug design and protein engineering across disease areas.

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company developing products for the eye care market.

The company Nosocom Solutions Inc. focuses on the development of technology solutions to prevent and reduce Healthcare Associated Infections (HAI).

Newomics Inc. is dedicated to creating and commercializing innovative (New) and integrative (Omics) platforms and solutions for precision medicine.

The Nan?mix Point Of Care system includes a hand-held, battery powered instrument and a microfluidic test cartridge that utilizes Carbon Nanotube biosensors to deliver clinical laboratory performance in a point of care or mobile setting.

Nano Precision Medical (NPM) is developing a small, easily-implantable, all-titanium capsule that provides long-term, constant-rate delivery of therapeutic molecules using a proprietary titania nanoporous membrane technology called NanoPortalTM.